Market Overview:
The global needle-free diabetes care market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in needle-free devices, and rising demand for minimally invasive treatments. Based on type, the insulin patches segment is expected to account for the largest share of the global needle-free diabetes care market in 2018. This segment is projected to grow at a CAGR of 8.1% during the forecast period from 2018 to 2030. The growth in this segment can be attributed to factors such as increasing preference for minimally invasive treatments and growing awareness about insulin patches among patients with diabetes mellitus (DM). Based on application, diagnostic centers are expected to account for the largest share of the global needle-free diabetes care market in 2018.
Product Definition:
Needle-free diabetes care is the delivery of diabetes treatments without the use of needles. This can be done through various methods, such as injections, infusions, or inhalers. Needle-free care is important because it allows people with diabetes to easily and discreetly administer their treatments. It also eliminates the risk of needle stick injuries.
Insulin Patches:
Insulin Patches are small adhesive devices that can be applied to the skin. They work by allowing insulin to flow through the body where it is absorbed by cells. The product has been developed as an alternative for patients who cannot use needles and have difficulty in applying liquid medicines.
Insulin patches are a new approach in diabetes treatment, currently being used only for type 1 diabetes patients, but with potential applications extending to other forms of the disease in the future if proven effective and safe enough.
Jet Injectors:
Jet injectors are devices that are used to inject insulin into the patient with a high speed and accuracy. It is one of the fastest-growing technology in diabetes care as it helps in reducing human errors while injecting insulin. The major benefit of jet injectors is that there’s no need for a needle, hence it’s known as needle-free injection devices.
Application Insights:
On the basis of application, the global needle-free diabetes care market is segmented into consumer, diagnostic centers, hospitals and clinics and others. The consumer segment held a major share in 2017 due to increasing awareness about diabetes among individuals at an early age. Moreover, rising disposable income has enabled consumers to spend on medical devices that improve their health outcomes.
The hospital and clinic segment is expected to grow significantly over the forecast period owing to growing prevalence of diabetes coupled with increasing government funding for the treatment of diabetic patients in low-income countries such as India and China. For instance, according to data published by National Diabetes Foundation (NDF), India distributed funds worth USD 41 million under ¢â‚¬Å“Pradhan Mantri Jan Dhan Yojana¢â‚¬ in 2016 while China allocated USD 28 million through its rural credit management program between April 2015 and March 2016.
Regional Analysis:
North America dominated the global needle-free diabetes care market in 2017. This can be attributed to the presence of a large number of manufacturers, distributors, and retailers that offer these products. The region is expected to maintain its dominance throughout the forecast period owing to increasing awareness about new technologies among people with diabetes as well as their doctors. Europe also contributed significantly towards market share in 2017 due to growing product adoption by patients and rising healthcare expenditure by governments for developing advanced therapies for diabetic patients.
Growth Factors:
- Increasing prevalence of diabetes: The global prevalence of diabetes is increasing at an alarming rate. This is primarily due to the changing lifestyle and dietary habits of people across the world. As a result, there is an increased demand for needle-free diabetes care products and services.
- Technological advancements: The development of new technologies has led to the introduction of innovative needle-free diabetes care products and devices in the market. This is helping to drive growth in this market segment.
- Growing awareness about needle-free diabetes care products: There is a growing awareness among people about the benefits of using needle-free diabetes care products over traditional methods such as injections and blood glucose meters etcetera .This is helping to boost demand for these products worldwide .
Scope Of The Report
Report Attributes
Report Details
Report Title
Needle-Free Diabetes Care Market Research Report
By Type
Insulin Patches, Jet Injectors, Insulin Pens, Insulin Pumps, Insulin Infuser
By Application
Consumer, Diagnostic Centers, Hospitals and Clinics
By Companies
Antares Pharma, European Pharma Group, Johnson and Johnson, Injex UK, Echo Therapeutics, MannKind Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
221
Number of Tables & Figures
155
Customization Available
Yes, the report can be customized as per your need.
Global Needle-Free Diabetes Care Market Report Segments:
The global Needle-Free Diabetes Care market is segmented on the basis of:
Types
Insulin Patches, Jet Injectors, Insulin Pens, Insulin Pumps, Insulin Infuser
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Consumer, Diagnostic Centers, Hospitals and Clinics
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Antares Pharma
- European Pharma Group
- Johnson and Johnson
- Injex UK
- Echo Therapeutics
- MannKind Corporation
Highlights of The Needle-Free Diabetes Care Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Insulin Patches
- Jet Injectors
- Insulin Pens
- Insulin Pumps
- Insulin Infuser
- By Application:
- Consumer
- Diagnostic Centers
- Hospitals and Clinics
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Needle-Free Diabetes Care Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Needle-free diabetes care is a type of diabetes care that does not involve the use of needles. This type of care can be helpful for people who are uncomfortable with the idea of having needles inserted into their bodies.
Some of the major players in the needle-free diabetes care market are Antares Pharma, European Pharma Group, Johnson and Johnson, Injex UK, Echo Therapeutics, MannKind Corporation.
The needle-free diabetes care market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Needle-Free Diabetes Care Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Needle-Free Diabetes Care Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Needle-Free Diabetes Care Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Needle-Free Diabetes Care Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Needle-Free Diabetes Care Market Size & Forecast, 2020-2028
4.5.1 Needle-Free Diabetes Care Market Size and Y-o-Y Growth
4.5.2 Needle-Free Diabetes Care Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Insulin Patches
5.2.2 Jet Injectors
5.2.3 Insulin Pens
5.2.4 Insulin Pumps
5.2.5 Insulin Infuser
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Consumer
6.2.2 Diagnostic Centers
6.2.3 Hospitals and Clinics
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Needle-Free Diabetes Care Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Needle-Free Diabetes Care Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Insulin Patches
9.6.2 Jet Injectors
9.6.3 Insulin Pens
9.6.4 Insulin Pumps
9.6.5 Insulin Infuser
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Consumer
9.10.2 Diagnostic Centers
9.10.3 Hospitals and Clinics
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Insulin Patches
10.6.2 Jet Injectors
10.6.3 Insulin Pens
10.6.4 Insulin Pumps
10.6.5 Insulin Infuser
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Consumer
10.10.2 Diagnostic Centers
10.10.3 Hospitals and Clinics
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Insulin Patches
11.6.2 Jet Injectors
11.6.3 Insulin Pens
11.6.4 Insulin Pumps
11.6.5 Insulin Infuser
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Consumer
11.10.2 Diagnostic Centers
11.10.3 Hospitals and Clinics
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Insulin Patches
12.6.2 Jet Injectors
12.6.3 Insulin Pens
12.6.4 Insulin Pumps
12.6.5 Insulin Infuser
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Consumer
12.10.2 Diagnostic Centers
12.10.3 Hospitals and Clinics
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Insulin Patches
13.6.2 Jet Injectors
13.6.3 Insulin Pens
13.6.4 Insulin Pumps
13.6.5 Insulin Infuser
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Consumer
13.10.2 Diagnostic Centers
13.10.3 Hospitals and Clinics
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Needle-Free Diabetes Care Market: Competitive Dashboard
14.2 Global Needle-Free Diabetes Care Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Antares Pharma
14.3.2 European Pharma Group
14.3.3 Johnson and Johnson
14.3.4 Injex UK
14.3.5 Echo Therapeutics
14.3.6 MannKind Corporation
